Cipla and BioQuiddity announce EU Commercial Partnership for OneDose-ReadyfusOR for Post-Surgical Pain Management

Cipla appoints Mr. Adil Zainulbhai as an Independent Director on the Board

The Medicines Patent Pool Signs A Record Seven New Sub-Licences to Speed the Availability of Generic HIV Medicines to Developing Countries

Cipla to expand global footprint, plans investment in its UK subsidiary

Cipla collaborates with Hetero to launch its second biosimilar drug ‘Darbepoetin alfa’

Cipla collaborates with Hetero to launch its second biosimilar drug ‘Darbepoetin alfa’

Cipla announces Q4 FY1314 Audited Consolidated Financial Results

Cipla invests in Chase Pharmaceuticals to support Alzheimer’s disease drug development

MSD and Cipla announce India-specific Strategic Partnership to Co-market MSD’s raltegravir 400mg tablet, for Indian Market

Cipla announces Q3 FY1314 Unaudited Consolidated Financial Results